A closer look: factors impacting HIV durable viral suppression among a cohort of clinic attendees in Trinidad & Tobago

Background In Trinidad and Tobago, high HIV prevalence among key populations necessitates studying factors that impact durable viral suppression (DVS), crucial for effective HIV management and reducing transmission among at-risk networks. This study investigates these factors using clinical data fro...

Full description

Saved in:
Bibliographic Details
Main Authors: Elena Cyrus, Deidre A. Okeke, Omari Lavia, Mary Jo Trepka, Allysha Maragh-Bass, Lunthita Duthely, Michael Sciauodone, Jeffrey Edwards
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:HIV Research & Clinical Practice
Subjects:
Online Access:http://dx.doi.org/10.1080/25787489.2024.2443886
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593453563772928
author Elena Cyrus
Deidre A. Okeke
Omari Lavia
Mary Jo Trepka
Allysha Maragh-Bass
Lunthita Duthely
Michael Sciauodone
Jeffrey Edwards
author_facet Elena Cyrus
Deidre A. Okeke
Omari Lavia
Mary Jo Trepka
Allysha Maragh-Bass
Lunthita Duthely
Michael Sciauodone
Jeffrey Edwards
author_sort Elena Cyrus
collection DOAJ
description Background In Trinidad and Tobago, high HIV prevalence among key populations necessitates studying factors that impact durable viral suppression (DVS), crucial for effective HIV management and reducing transmission among at-risk networks. This study investigates these factors using clinical data from a major HIV care clinic in the Caribbean. Methods A retrospective analysis of 533 adult people with HIV (people) at MRFTT from 2017 to 2021 assessed the proportion achieving DVS, defined as a sustained viral load <200 copies/ml over one year. Initial univariate analysis characterized individuals with DVS, followed by bivariate analysis to explore socio-demographic differences. Significant variables from bivariate analysis were examined in a regression model to identify DVS covariates. Results The average age of the sample was 45 years (SD = 10.88), with 52.0% male and 72.1% of African descent. 31.5% achieved durable viral suppression (DVS). Those with DVS were predominantly women (54.1%), older (mean age 45, SD = 11.32), with more frequent clinic visits over five years (mean = 101, SD = 33.26). Regression analysis showed that women (OR = 1.43, 95% CI 0.99–2.07), individuals on long-term antiretroviral therapy (ART) (>5 years) (OR = 1.66, 95% CI 1.03–2.66), and those with extended clinic enrolment (>5 years) (OR = 1.82, 95% CI 1.08–3.06) had higher odds of achieving DVS. Conclusions Only a third of the study sample achieved DVS, with men less likely to reach this goal. Lesser engagement in care correlated with lower DVS rates. Further research into social and structural barriers to clinic attendance, particularly among younger men, is recommended.
format Article
id doaj-art-1bcbaa9e70a74ec69490ce2aea07772d
institution Kabale University
issn 2578-7470
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series HIV Research & Clinical Practice
spelling doaj-art-1bcbaa9e70a74ec69490ce2aea07772d2025-01-20T14:37:59ZengTaylor & Francis GroupHIV Research & Clinical Practice2578-74702025-12-0126110.1080/25787489.2024.24438862443886A closer look: factors impacting HIV durable viral suppression among a cohort of clinic attendees in Trinidad & TobagoElena Cyrus0Deidre A. Okeke1Omari Lavia2Mary Jo Trepka3Allysha Maragh-Bass4Lunthita Duthely5Michael Sciauodone6Jeffrey Edwards7Department of Population Health Sciences, College of Medicine, University of Central FloridaDepartment of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International UniversityMedical Research Foundation of Trinidad and TobagoDepartment of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International UniversityGlobal Health and Population ResearchMiller School of Medicine, University of MiamiSchool of Medicine, Tulane UniversityMedical Research Foundation of Trinidad and TobagoBackground In Trinidad and Tobago, high HIV prevalence among key populations necessitates studying factors that impact durable viral suppression (DVS), crucial for effective HIV management and reducing transmission among at-risk networks. This study investigates these factors using clinical data from a major HIV care clinic in the Caribbean. Methods A retrospective analysis of 533 adult people with HIV (people) at MRFTT from 2017 to 2021 assessed the proportion achieving DVS, defined as a sustained viral load <200 copies/ml over one year. Initial univariate analysis characterized individuals with DVS, followed by bivariate analysis to explore socio-demographic differences. Significant variables from bivariate analysis were examined in a regression model to identify DVS covariates. Results The average age of the sample was 45 years (SD = 10.88), with 52.0% male and 72.1% of African descent. 31.5% achieved durable viral suppression (DVS). Those with DVS were predominantly women (54.1%), older (mean age 45, SD = 11.32), with more frequent clinic visits over five years (mean = 101, SD = 33.26). Regression analysis showed that women (OR = 1.43, 95% CI 0.99–2.07), individuals on long-term antiretroviral therapy (ART) (>5 years) (OR = 1.66, 95% CI 1.03–2.66), and those with extended clinic enrolment (>5 years) (OR = 1.82, 95% CI 1.08–3.06) had higher odds of achieving DVS. Conclusions Only a third of the study sample achieved DVS, with men less likely to reach this goal. Lesser engagement in care correlated with lower DVS rates. Further research into social and structural barriers to clinic attendance, particularly among younger men, is recommended.http://dx.doi.org/10.1080/25787489.2024.2443886durable viral suppressionpeople with hivtrinidad and tobagogenderdisparities
spellingShingle Elena Cyrus
Deidre A. Okeke
Omari Lavia
Mary Jo Trepka
Allysha Maragh-Bass
Lunthita Duthely
Michael Sciauodone
Jeffrey Edwards
A closer look: factors impacting HIV durable viral suppression among a cohort of clinic attendees in Trinidad & Tobago
HIV Research & Clinical Practice
durable viral suppression
people with hiv
trinidad and tobago
gender
disparities
title A closer look: factors impacting HIV durable viral suppression among a cohort of clinic attendees in Trinidad & Tobago
title_full A closer look: factors impacting HIV durable viral suppression among a cohort of clinic attendees in Trinidad & Tobago
title_fullStr A closer look: factors impacting HIV durable viral suppression among a cohort of clinic attendees in Trinidad & Tobago
title_full_unstemmed A closer look: factors impacting HIV durable viral suppression among a cohort of clinic attendees in Trinidad & Tobago
title_short A closer look: factors impacting HIV durable viral suppression among a cohort of clinic attendees in Trinidad & Tobago
title_sort closer look factors impacting hiv durable viral suppression among a cohort of clinic attendees in trinidad tobago
topic durable viral suppression
people with hiv
trinidad and tobago
gender
disparities
url http://dx.doi.org/10.1080/25787489.2024.2443886
work_keys_str_mv AT elenacyrus acloserlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT deidreaokeke acloserlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT omarilavia acloserlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT maryjotrepka acloserlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT allyshamaraghbass acloserlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT lunthitaduthely acloserlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT michaelsciauodone acloserlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT jeffreyedwards acloserlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT elenacyrus closerlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT deidreaokeke closerlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT omarilavia closerlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT maryjotrepka closerlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT allyshamaraghbass closerlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT lunthitaduthely closerlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT michaelsciauodone closerlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago
AT jeffreyedwards closerlookfactorsimpactinghivdurableviralsuppressionamongacohortofclinicattendeesintrinidadtobago